Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Preclinical and clinical laboratory markers in chronic coronary syndromes Inflammation and Immunity ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by